FDG PET in the Evaluation of Parkinson's Disease
- PMID: 20689674
- PMCID: PMC2913894
- DOI: 10.1016/j.cpet.2009.12.004
FDG PET in the Evaluation of Parkinson's Disease
Abstract
Network analysis of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is an innovative approach for the study of in movement disorders, such as Parkinson's disease (PD). Spatial covariance analysis of imaging data acquired from PD patients has revealed characteristic regional patterns associated with the motor and cognitive features of disease. Quantification of pattern expression in individual patients can be used for diagnosis, assessment of disease severity, and evaluation of novel medical and surgical therapies. Identification of disease-specific patterns in other parkinsonian syndromes, such as multiple system atrophy and progressive supranuclear palsy, has improved diagnostic accuracy in patients with difficult to diagnose parkinsonism. Further developments of these techniques are likely to enhance the role of functional imaging in investigating underlying abnormalities and potential new therapies in these neurodegenerative diseases.
Figures




Similar articles
-
The utility of FDG-PET in the differential diagnosis of Parkinsonism.Neurol Res. 2017 Aug;39(8):675-684. doi: 10.1080/01616412.2017.1312211. Epub 2017 Apr 5. Neurol Res. 2017. PMID: 28378615
-
18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment.J Nucl Med. 2017 Dec;58(12):1888-1898. doi: 10.2967/jnumed.116.186403. Epub 2017 Sep 14. J Nucl Med. 2017. PMID: 28912150 Review.
-
FDG PET in the differential diagnosis of parkinsonian disorders.Neuroimage. 2005 Jul 1;26(3):912-21. doi: 10.1016/j.neuroimage.2005.03.012. Epub 2005 Apr 26. Neuroimage. 2005. PMID: 15955501
-
[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.Neurology. 2012 Sep 25;79(13):1314-22. doi: 10.1212/WNL.0b013e31826c1b0a. Epub 2012 Aug 22. Neurology. 2012. PMID: 22914831
-
[Differential diagnostics of Parkinson's disease with nuclear medicine procedures].Nervenarzt. 2014 Jun;85(6):680-9. doi: 10.1007/s00115-013-3995-1. Nervenarzt. 2014. PMID: 24821290 Review. German.
Cited by
-
Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1534-1545. doi: 10.1007/s00259-018-4031-2. Epub 2018 May 19. Eur J Nucl Med Mol Imaging. 2018. PMID: 29779045 Free PMC article. Review.
-
The history of cerebral PET scanning: from physiology to cutting-edge technology.Neurology. 2013 Mar 5;80(10):952-6. doi: 10.1212/WNL.0b013e318285c135. Neurology. 2013. PMID: 23460618 Free PMC article. Review.
-
MRI biomarkers of motor and non-motor symptoms in Parkinson's disease.Parkinsonism Relat Disord. 2020 Apr;73:85-93. doi: 10.1016/j.parkreldis.2019.10.002. Epub 2019 Oct 10. Parkinsonism Relat Disord. 2020. PMID: 31629653 Free PMC article. Review.
-
Data-driven, voxel-based analysis of brain PET images: Application of PCA and LASSO methods to visualize and quantify patterns of neurodegeneration.PLoS One. 2018 Nov 5;13(11):e0206607. doi: 10.1371/journal.pone.0206607. eCollection 2018. PLoS One. 2018. PMID: 30395576 Free PMC article.
-
Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms.Mov Disord Clin Pract. 2021 Nov 15;9(1):6-19. doi: 10.1002/mdc3.13354. eCollection 2022 Jan. Mov Disord Clin Pract. 2021. PMID: 35005060 Free PMC article. Review.
References
-
- de Rijk MC, Breteler MM, Graveland GA, et al. Prevalence of Parkinson’s disease in the elderly: the Rotterdam Study. Neurology. 1995;45(12):2143–6. - PubMed
-
- Hely MA, Morris JG, Reid WG, et al. Sydney Multicenter Study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005;20(2):190–9. - PubMed
-
- Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23(6):837–44. - PubMed
-
- Hughes AJ, Daniel SE, Ben-Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125(Pt 4):861–70. - PubMed
-
- O’Sullivan SS, Massey LA, Williams DR, et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain. 2008;131(Pt 5):1362–72. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources